Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation

Por um escritor misterioso
Last updated 18 novembro 2024
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Ritedose Sodium Chloride for Inhalation 7% Unit Dose 4 mL Ampule
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Pfizer 00409729973 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Pfizer Hospital US
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
News – Page 2 – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Fresenius USA 63323018620 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Almaject Inc 47781058629 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Ritedose Pharmaceuticals – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Hospira 00409490334 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Fresenius USA 63323048257 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
News – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Pfizer Hospital US
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Cardinal 8881570300 - McKesson Medical-Surgical

© 2014-2024 tokoonline2.msd.biz.id. All rights reserved.